Search Results
Mar 24, 2026, 04:21 ET Construction Equipment Rental Market to Reach USD 217 Billion by 2032 Amid Infrastructure Expansion and Cost-Efficient Equipment Access | Vyansa Intelligence
Highway, Manufacturing Units, OthersBy Engine Capacity: <5L, 5–10L, >10LBy Power Output: <100 HP, 101–200 HP, 201–400 HP, >400 HPBy Region: North America, Europe, Asia-Pacific, Middle East & Africa, South AmericaBrowse More Reports
More news about: Vyansa Intelligence
Mar 24, 2026, 01:47 ET Avid Organics 將於巴黎 in-cosmetics® Global 展會上推出全球首款商業規模生產的生物基乙醇酸 AviGa™ Bio HP70
Organics，正正致力填補此市場缺口。 2026 年 4 月 14 日，公司將於巴黎 in-cosmetics® Global 展會上發佈 AviGa™ Bio HP70，成為全球首款商業規模生產的生物基乙醇酸。 此產品全以植物為原料，在 100% 可再生能源驅動的尖端設施中產生。此外，該產品已取得歐洲市場必需的 REACH 註冊認證，並憑藉 Avid 在全球受監管行業中長達 18 年的豐富經驗提供專業服務。AviGa™ Bio HP70 是 70% 化妝品級溶液，符合受監管的個人護理、化妝品和製藥應用領域對純度的嚴格要求。 生產過程嚴謹管控微量雜質，尤其是那些常見於石油基乙醇酸的甲醛、甲氧基乙酸和二氯乙酸等。
More news about: Avid Organics
Mar 24, 2026, 00:01 ET India Solar Pump Market Set for Steady Expansion, Expected to Reach USD 248 Million by 2032 | MarkNtel Advisors
Type: Submersible Pumps, Surface PumpsBy Operation: AC Pumps, DC PumpsBy Power Rating: Upto 5 HP, 5.1–10 HP, 10.1–15 HP, 15.1–20 HP, Above 20 HPBy End User: Agriculture, Industrial, ResidentialBy Region: East India, North India, West India,
More news about: MarkNtel Advisors
Mar 23, 2026, 10:00 ET IBM Debuts New AI Enabled Digital Experiences for the 90th Masters Tournament
other iconic sports and entertainment organizations – Scuderia Ferrari HP, Wimbledon, the
More news about: IBM
Mar 23, 2026, 09:03 ET Engage by Karma Offers On-Demand Access to Personal Mobility Options, Curated Travel, and Retail Experiences
Coupé, a Hybrid EREV four-seater, is due in Q2 2026; and the Amaris GT Coupé Hybrid EREV arrives in Q4 2026. The Karma Kaveya super-coupe, with over 1,000HP and butterfly-doors, will arrive in Q4 2027, and the Karma Ivara GT-UV will arrive in 2028: both EVs will incorporate SDVA (Software-Defined Vehicle
More news about: Karma Automotive
Mar 23, 2026, 08:46 ET AM General is Driving Innovation at AUSA Global Force 2026 with Unmanned Ground Vehicle Debut
powerful, fuel-flexible performance with advanced cooling and injection. Utilizing a common rail direct injection fuel system, the new engine can produce 250hp and over 550lb-ft of torque. Not only will this new engine power the UGV, but it will also underpin future light tactical vehicles, including the ever-evolving
More news about: AM General LLC
Mar 21, 2026, 15:50 ET EL LEXUS ES 2026 SALE AL MERCADO CON MODELOS TOTALMENTE ELÉCTRICOS; EL NUEVO HÍBRIDO LLEGARÁ PRONTO
221 hp que impulsa la rueda delantera, y un tiempo estimado de 0 a 60 mph de 7.4 segundos.El ES 500e incluye el mismo motor delantero de 221 hp que el ES 350e y agrega un motor eléctrico síncrono de imanes permanentes de 118 hp al eje trasero para una potencia neta total combinada de 338 hp y tracción
More news about: Lexus
Mar 20, 2026, 12:30 ET BOMA International Begins Canvassing Process for Latest Mixed-Use Properties Standard
training to industry professionals, delivering more than 400,000 courses and 43,000 credentials through its designations (RPA®, FMA®, SMT®, SMA®, and BOMI-HP®) and certificate programs. This training has a proven record of enhancing job performance and company efficiency. For more info, visit boma.org.
More news about: Building Owners and Managers Association International
Mar 20, 2026, 10:31 ET Water Taxi Market Size to Reach USD 315.31 Billion by 2032, Reveals New Maximize Market Research Analysis
BoatBy Propulsion Type OutboardInboardOthersBy Propulsion Output <300 HP300 HP - 600 HP> 600 HPBy Power TypeMotorizedBattery Powered Or ElectricDieselHybridNon-MotorizedImmediate
More news about: Maximize Market Research Pvt. Ltd.
Mar 19, 2026, 03:46 ET hl1Mining Equipment Market to Reach USD 154.84 Billion by 2032 Amid Rising Global Mineral Demand and Expansion of Large-Scale Mining Projects, Says MarkNtel Advisors
Crushers, Drills & Breakers, OthersBy Power Source: Diesel, Electric, Hybrid SystemsBy Power Output: <500 HP, 500–2000 HP, >2000 HPBy Automation Level: Manual Equipment, Semi-Autonomous Equipment, Fully Autonomous EquipmentBy Application: Metal
More news about: MarkNtel Advisors
Mar 19, 2026, 03:14 ET Avid Organics、パリで開催される「in-cosmetics® Global」で世界初の商業規模バイオベース・グリコール酸「AviGa™ Bio HP70」を発表
AviGa™ Bio HP70は、バイオベースの化粧品グレードの70%グリコール酸であり、REACH登録による欧州への安定した供給を確保しながら、2026年4月14日より世界中で提供を開始この発表は、100年以上の歴史を持つ石油由来原料に代わる、持続可能で追跡可能な代替品を商業規模で提供するものであり、パーソナル・ケア、化粧品、および製薬業界にとって極めて重要な転換点となります。ヴァドダラ、インド、,
More news about: Avid Organics
Mar 19, 2026, 01:20 ET 에이비드 오가닉스, 파리 인-코스메틱스 글로벌에서 세계 최초 상업 규모 바이오 기반 글리콜산 AviGa™ Bio HP70 출시 예정
인-코스메틱스® 글로벌(in-cosmetics® Global)에서 전 세계 최초로 상업 규모에 도달한 바이오 기반 글리콜산 AviGa™ Bio HP70을 공개할 예정이다. 전적으로 식물성 원료로 생산되는 이 제품은 100% 재생 가능 에너지로 구동되는 첨단 제조 인프라, 유럽 시장을 위한 REACH 등록, 그리고 에이비드의 18년간 전 세계 규제 산업 서비스 실적을 바탕으로 한다.AviGa™ Bio HP70은 규제 대상 퍼스널 케어, 화장품, 제약 애플리케이션의 엄격한 순도 요구 사항을 충족하는 70% 화장품 등급 용액이다. 제조 공정은
More news about: Avid Organics
Mar 18, 2026, 20:06 ET Avid Organics stellt auf der in-cosmetics® Global in Paris die weltweit erste biobasierte Glykolsäure auf kommerzieller Basis, AviGa™ Bio HP70, vor
AviGa™ Bio HP70 ist eine biobasierte 70%ige kosmetische Glykolsäure, die ab dem 14. April 2026 weltweit erhältlich ist und deren REACH-Registrierung eine ununterbrochene Versorgung Europas gewährleistet.Die Markteinführung markiert einen entscheidenden Wendepunkt
More news about: Avid Organics
Mar 18, 2026, 17:03 ET 2026 LEXUS ES LAUNCHES WITH BATTERY-ELECTRIC MODELS, NEW HYBRID COMING SOON
passenger compartment. The ES 350e has a single 221-hp permanent magnet synchronous electric motor powering the front wheel, and an estimated 0-60 mph time of 7.4 seconds.The ES 500e includes the same 221-hp front motor as the ES 350e and adds a 118-hp permanent magnet synchronous electric motor to
More news about: Lexus
Mar 18, 2026, 09:15 ET Avid Organics lance le premier acide glycolique bio à l'échelle commerciale au monde, AviGa™ Bio HP70, au salon in-cosmetics® Global à Paris
AviGa™ Bio HP70 est un acide glycolique biosourcé à 70 % de qualité cosmétique disponible à l'échelle mondiale à partir du 14 avril 2026, l'enregistrement REACH garantissant un approvisionnement européen ininterrompuCe lancement marque un tournant pour les industries
More news about: Avid Organics
Mar 18, 2026, 09:12 ET Avid Organics lanzará AviGa™ Bio HP70, el primer ácido glicólico de base biológica del mundo
Avid Organics lanzará el primer ácido glicólico de base biológica a escala comercial del mundo, AviGa™ Bio HP70, en in-cosmetics® Global en ParísAviGa™ Bio HP70 es un ácido glicólico de grado cosmético al 70 % de origen biológico, disponible a nivel mundial a partir del
More news about: Avid Organics
Mar 18, 2026, 07:43 ET Avid Organics lanzará el primer ácido glicólico de base biológica a escala comercial del mundo, AviGa™ Bio HP70, en in-cosmetics® Global en París
AviGa™ Bio HP70 es un ácido glicólico de base biológica, 70 % de calidad cosmética, disponible en todo el mundo a partir del 14 de abril de 2026, con registro REACH que garantiza un suministro europeo ininterrumpidoEl lanzamiento marca un cambio fundamental para
More news about: Avid Organics
Mar 18, 2026, 07:32 ET Avid Organics lança o primeiro ácido glicólico de base biológica em escala comercial do mundo, o AviGa™ Bio HP70, na in-cosmetics® Global em Paris
AviGa™ Bio HP70 é um ácido glicólico de base biológica, 70% de grau cosmético disponível globalmente a partir de 14 de abril de 2026, com registro REACH garantindo o fornecimento europeu ininterruptoO lançamento marca uma mudança fundamental para as indústrias
More news about: Avid Organics
Mar 18, 2026, 05:02 ET Avid Organics to Launch the World's First Commercial-Scale Bio-Based Glycolic Acid, AviGa™ Bio HP70, at in-cosmetics® Global in Paris
AviGa™ Bio HP70 is a bio-based, 70% cosmetic-grade glycolic acid available globally from April 14, 2026, with REACH registration ensuring uninterrupted European supplyThe launch marks a pivotal shift for personal care, cosmetics, and pharmaceutical industries by
More news about: Avid Organics
Mar 18, 2026, 04:58 ET Avid Organics to Launch the World's First Commercial-Scale Bio-Based Glycolic Acid, AviGa™ Bio HP70, at in-cosmetics® Global in Paris
AviGa™ Bio HP70 is a bio-based, 70% cosmetic-grade glycolic acid available globally from April 14, 2026, with REACH registration ensuring uninterrupted European supplyThe launch marks a pivotal shift for personal care, cosmetics, and pharmaceutical industries by
More news about: Avid Organics
Mar 17, 2026, 18:51 ET Desde lavadoras a presión hasta patios: el evento Spring Starts de The Home Depot inicia la temporada de descuentos
juego de dos herramientas RYOBI HP 18V Brushless de 4.0 Ah, la
More news about: The Home Depot
Mar 17, 2026, 09:01 ET Colgate Optic White Unveils Its Most Advanced Whitening Formula: The New Optic White Pro Series Toothpaste
polished finish," says Amy Benford, SVP, IMC & Advanced Advertising. "Our new Colgate Optic White Pro Series toothpaste is the answer. We've paired our HP Complex, which harnesses the stain-dissolving power of hydrogen peroxide, with our new ActivShine Technology to push beyond conventional whitening, helping
More news about: Colgate
Mar 17, 2026, 08:00 ET From Power Washers to Patios: The Home Depot's Spring Starts Event Kicks off Season of Savings
RYOBI HP 18V Brushless 2-Tool 4.0Ah Kit,
More news about: The Home Depot
Mar 17, 2026, 07:35 ET Knight Therapeutics anuncia submissão regulatória suplementar de MINJUVI® (tafasitamabe) para linfoma folicular na Argentina e no México
Epidemiology Resource. J Clin Oncol 2013;31:3272-3278.Sehn LH, Luminari S, Scholz CW, Hübel K, Salar A, Paneesha S, Wahlin BE, Panayiotidis P, Lee HP, Jiménez Ubieto A, Sancho JM, Kim TM, Domingo Domenech E, Kumode T, Poh C, Thieblemont C, Deeren D, de Wit E, Arbushites M, Casadebaig ML, Trneny M. Tafasitamab
More news about: Knight Therapeutics Inc.
Mar 17, 2026, 07:35 ET Knight Therapeutics Anuncia Aprovação de Indicação Adicional para MINJUVI® (tafasitamabe) no Brasil
https://www.orpha.net/en/disease/detail/545Sehn LH, Luminari S, Scholz CW, Hübel K, Salar A, Paneesha S, Wahlin BE, Panayiotidis P, Lee HP, Jiménez Ubieto A, Sancho JM, Kim TM, Domingo Domenech E, Kumode T, Poh C, Thieblemont C, Deeren D, de Wit E, Arbushites M, Casadebaig ML, Trneny M. Tafasitamab
More news about: Knight Therapeutics Inc.